Empowered Funds
ATNM icon

Empowered Funds’s Actinium Pharmaceuticals ATNM Stock Holding History

Empowered Funds’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$44.1K Buy
+39,354
New +$39.9K ﹤0.01% 2484

Other funds holding ATNM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Compass Financial Management
Compass Financial Management Tampa, Florida $926M AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
AIS
AM Investment Strategies Chattanooga, Tennessee $535M AUM 22.04% 1-Year Est. Return

Empowered Funds's ATNM Position: Q3 2026 in Review

Empowered Funds opened a new position in Actinium Pharmaceuticals (ATNM) in Q3 2026: 39,354 shares worth $44.1K. The stake represents ﹤0.01% of the portfolio and ranks #2484 among its holdings.

38 funds tracked by Wall St. Rank hold ATNM as of Q3 2026.

  • Empowered Funds held 39,354 shares of Actinium Pharmaceuticals worth $44.1K as of Q3 2026.
  • Actinium Pharmaceuticals was a new Empowered Funds position in Q3 2026.
  • Actinium Pharmaceuticals made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2484 holding.
  • 38 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.